3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
67
Pancreatic Neoplasms
34
Neoplasm Metastasis
22
Neuroblastoma
21
Neoplasms
16
Colonic Neoplasms
15
Stomach Neoplasms
13
Rectal Neoplasms
13
Sarcoma, Ewing
8
Rhabdomyosarcoma
8
Esophageal Squamous Cell Carcinoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Ovarian Neoplasms
6
Lung Neoplasms
6
Cholangiocarcinoma
6
Esophageal Neoplasms
5
Breast Neoplasms
5
Adenocarcinoma Of Esophagus
5
Medulloblastoma
4
Gastrointestinal Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma
4
Recurrence
3
Parkinson Disease 4, Autosomal Dominant Lewy Body
3
Osteosarcoma
3
Glioma
3
Glioblastoma
3
Ganglioneuroblastoma
3
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Irinotecan
×
1 year
×
Clear all
No trials found.